These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28102477)

  • 1. Potential new mechanisms of pro-arrhythmia in arrhythmogenic cardiomyopathy: focus on calcium sensitive pathways.
    van Opbergen CJ; Delmar M; van Veen TA
    Neth Heart J; 2017 Mar; 25(3):157-169. PubMed ID: 28102477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.
    van der Zwaag PA; van Rijsingen IA; Asimaki A; Jongbloed JD; van Veldhuisen DJ; Wiesfeld AC; Cox MG; van Lochem LT; de Boer RA; Hofstra RM; Christiaans I; van Spaendonck-Zwarts KY; Lekanne dit Deprez RH; Judge DP; Calkins H; Suurmeijer AJ; Hauer RN; Saffitz JE; Wilde AA; van den Berg MP; van Tintelen JP
    Eur J Heart Fail; 2012 Nov; 14(11):1199-207. PubMed ID: 22820313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Heterozygous
    Mo H; Hua X; Bao M; Sun Z; Chen X; Xu M; Song J
    Phenomics; 2024 Feb; 4(1):13-23. PubMed ID: 38605909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).
    Doevendans PA; Glijnis PC; Kranias EG
    Circ Res; 2019 Sep; 125(7):720-724. PubMed ID: 31513489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.
    Mazzocchi G; Sommese L; Palomeque J; Felice JI; Di Carlo MN; Fainstein D; Gonzalez P; Contreras P; Skapura D; McCauley MD; Lascano EC; Negroni JA; Kranias EG; Wehrens XH; Valverde CA; Mattiazzi A
    J Physiol; 2016 Jun; 594(11):3005-30. PubMed ID: 26695843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct molecular signature of phospholamban p.Arg14del arrhythmogenic cardiomyopathy.
    Te Rijdt WP; Asimaki A; Jongbloed JDH; Hoorntje ET; Lazzarini E; van der Zwaag PA; de Boer RA; van Tintelen JP; Saffitz JE; van den Berg MP; Suurmeijer AJH
    Cardiovasc Pathol; 2019; 40():2-6. PubMed ID: 30763825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters.
    Stege NM; Eijgenraam TR; Oliveira Nunes Teixeira V; Feringa AM; Schouten EM; Kuster DWD; van der Velden J; Wolters AHG; Giepmans BNG; Makarewich CA; Bassel-Duby R; Olson EN; de Boer RA; Silljé HHW
    Circ Res; 2023 Dec; 133(12):1006-1021. PubMed ID: 37955153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
    Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
    Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy.
    Dokuparti MVN; Pamuru PR; Thakkar B; Tanjore RR; Nallari P
    J Hum Genet; 2005; 50(8):375-381. PubMed ID: 16096717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts.
    Rogalska ME; Vafiadaki E; Erpapazoglou Z; Haghighi K; Green L; Mantzoros CS; Hajjar RJ; Tranter M; Karakikes I; Kranias EG; Stillitano F; Kafasla P; Sanoudou D
    Metabolism; 2023 Jan; 138():155344. PubMed ID: 36375644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmia Mechanism and Dynamics in a Humanized Mouse Model of Inherited Cardiomyopathy Caused by Phospholamban R14del Mutation.
    Raad N; Bittihn P; Cacheux M; Jeong D; Ilkan Z; Ceholski D; Kohlbrenner E; Zhang L; Cai CL; Kranias EG; Hajjar RJ; Stillitano F; Akar FG
    Circulation; 2021 Aug; 144(6):441-454. PubMed ID: 34024116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodelling of myocardial intercalated disc protein connexin 43 causes increased susceptibility to malignant arrhythmias in ARVC/D patients.
    Chen X; Chen L; Chen Z; Chen X; Song J
    Forensic Sci Int; 2017 Jun; 275():14-22. PubMed ID: 28288337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial expression profiles of candidate molecules in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia compared to those with dilated cardiomyopathy and healthy controls.
    Akdis D; Medeiros-Domingo A; Gaertner-Rommel A; Kast JI; Enseleit F; Bode P; Klingel K; Kandolf R; Renois F; Andreoletti L; Akdis CA; Milting H; Lüscher TF; Brunckhorst C; Saguner AM; Duru F
    Heart Rhythm; 2016 Mar; 13(3):731-41. PubMed ID: 26569459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic Left Ventricular Cardiomyopathy Associated With a Phospholamban Gene Mutation in a Young Female: A Case Report and Literature Review.
    Khan WJ; Asif M; Chaudhry HS; Aslam S; Nadeem I; Chowdhury MA
    J Community Hosp Intern Med Perspect; 2023; 13(4):21-25. PubMed ID: 37868239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca
    Vafiadaki E; Haghighi K; Arvanitis DA; Kranias EG; Sanoudou D
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rho-Kinase Inhibition During Early Cardiac Development Causes Arrhythmogenic Right Ventricular Cardiomyopathy in Mice.
    Ellawindy A; Satoh K; Sunamura S; Kikuchi N; Suzuki K; Minami T; Ikeda S; Tanaka S; Shimizu T; Enkhjargal B; Miyata S; Taguchi Y; Handoh T; Kobayashi K; Kobayashi K; Nakayama K; Miura M; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2015 Oct; 35(10):2172-84. PubMed ID: 26315406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.
    van den Hoogenhof MMG; Beqqali A; Amin AS; van der Made I; Aufiero S; Khan MAF; Schumacher CA; Jansweijer JA; van Spaendonck-Zwarts KY; Remme CA; Backs J; Verkerk AO; Baartscheer A; Pinto YM; Creemers EE
    Circulation; 2018 Sep; 138(13):1330-1342. PubMed ID: 29650543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholamban ablation rescues sarcoplasmic reticulum Ca(2+) handling but exacerbates cardiac dysfunction in CaMKIIdelta(C) transgenic mice.
    Zhang T; Guo T; Mishra S; Dalton ND; Kranias EG; Peterson KL; Bers DM; Brown JH
    Circ Res; 2010 Feb; 106(2):354-62. PubMed ID: 19959778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and cardiac phenotype of patients with a phospholamban mutation.
    Hof IE; van der Heijden JF; Kranias EG; Sanoudou D; de Boer RA; van Tintelen JP; van der Zwaag PA; Doevendans PA
    Neth Heart J; 2019 Feb; 27(2):64-69. PubMed ID: 30547415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.